Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by JohnBelgon Nov 19, 2019 2:52am

220 Views

Post# 30368160

RE:RE:RE:Winning at poker & winning with THTX stock

THTX over on NASDAQ dropped 12.20% during regular hours, then in after hours trading there was 1 trade at 4:02 of a mere 72 shares at $3.50, up 11.11%. Crazy trading? Pattern of something? Beats me.

John

ANALIAS00 wrote: Maybe because it is not a low price yet ;o)

JayjayUSA12007 wrote:
Think of this as a Sale event of THTX. If you truly believe in Thera potential, then why not buying at low price ?